|
KIAA1737 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62458935193399E-12 |
| Normal-vs-Stage2 |
4.21339996226067E-09 |
| Normal-vs-Stage3 |
1.61609947646468E-10 |
| Normal-vs-Stage4 |
3.79309994524846E-09 |
| Stage1-vs-Stage2 |
6.217400E-01 |
| Stage1-vs-Stage3 |
7.450400E-01 |
| Stage1-vs-Stage4 |
1.319840E-01 |
| Stage2-vs-Stage3 |
8.396200E-01 |
| Stage2-vs-Stage4 |
1.451990E-01 |
| Stage3-vs-Stage4 |
2.149800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
2.1993999954617E-09 |
| Normal-vs-Asian |
1.71084999999183E-05 |
| Caucasian-vs-AfricanAmerican |
2.610000E-01 |
| Caucasian-vs-Asian |
6.723800E-01 |
| AfricanAmerican-vs-Asian |
4.785000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62625468647093E-12 |
| Normal-vs-Female |
1.82986958918718E-12 |
| Male-vs-Female |
4.230400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.79900016894896E-10 |
| Normal-vs-Extreme_Weight |
2.01527683429958E-12 |
| Normal-vs-Obese |
1.22124532708767E-15 |
| Normal-vs-Extreme_Obese |
3.079600E-02 |
| Normal_Weight-vs-Extreme_Weight |
4.536600E-01 |
| Normal_Weight-vs-Obese |
8.957600E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.421200E-01 |
| Extreme_Weight-vs-Obese |
2.266800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.433400E-01 |
| Obese-vs-Extreme_Obese |
6.560600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.59321999999573E-05 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
3.44169137633799E-13 |
| Normal-vs-Age(81-100Yrs) |
1.64523950019202E-12 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.668200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.614400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.068410E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.265400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.623700E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.260340E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.88182802673964E-12 |
| Normal-VS-Type2 PRCC |
3.11729531077276E-11 |
| Normal-VS-KIRP CIMP |
5.35209999652508E-08 |
| Normal-VS-Unclassified PRCC |
9.79390002431302E-09 |
| Type1 PRCC-VS-Type2 PRCC |
5.250800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.994000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.938400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.450800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.347200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.091800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.43058914609173E-14 |
| Normal-vs-N1 |
5.45550049579901E-10 |
| Normal-vs-N2 |
2.75110000003131E-06 |
| N0-vs-N1 |
4.749000E-01 |
| N0-vs-N2 |
2.220800E-01 |
| N1-vs-N2 |
9.014500E-02 |
|
|
